Al-Rubeaan, Khalid
Bana, Faisal A.
Alruwaily, Fayez G.
Sheshah, Eman
Alnaqeb, Dhekra
AlQahtani, Awad M.
Ewais, Diaa
Al Juhani, Nassr
Hassan, Abdul-hameed
Youssef, Amira M.
Funding for this research was provided by:
AstraZeneca.
This article is maintained by: Elsevier
Article Title: Physicians' choices in the first- and second-line management of type 2 diabetes in the Kingdom of Saudi Arabia
Journal Title: Saudi Pharmaceutical Journal
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jsps.2020.01.014
Content Type: article
Copyright: © 2020 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.